Why Your OB-GYN Isn't the Right Doctor for Perimenopause Hormone Optimization

This is not a criticism of OB-GYNs. They are excellent physicians doing exactly what their training prepared them for. The problem is that their training did not prepare them for hormone optimization in perimenopause — and for most women, that is the doctor they turn to first.

An OB-GYN completes four years of residency focused on obstetrics, reproductive endocrinology (primarily fertility), gynaecologic surgery, and management of gynaecologic conditions. The average American OB-GYN residency program dedicates less than four hours of formal instruction to menopause management over four years. That is not a rumour. It is a documented gap reported in the research literature, and it has direct consequences for the care women receive.

What the OB-GYN Appointment Actually Covers

The typical OB-GYN visit for a woman in her 40s runs between 12 and 20 minutes. It covers cervical screening, breast health, contraception if still relevant, and any acute gynaecologic concerns. If a patient raises symptoms — weight gain, sleep disruption, anxiety, brain fog, libido changes — the OB-GYN is generally working with a tool set that was not designed for those complaints.

The honest answer in many cases is: "Your labs are in the normal range. Try to manage your stress. Maybe see your PCP about the sleep." This is not negligence. It is a physician operating at the edge of their training being honest about what they can offer. But for the woman on the other side of the conversation, it is another dead end in a long series of them.

What the Right Specialist Looks Like

A physician who specializes in hormone optimization is not a different credential — it is a different focus and depth of experience. They approach perimenopause as a metabolic and endocrinological condition, not primarily a gynaecologic one. The assessment is comprehensive: complete hormone panels, metabolic markers, and a review of symptoms against the lab picture. The treatment is individualized: dosing decisions are based on your results, your response, and your goals — not a standard protocol.

This physician also knows when not to prescribe. There are women for whom bioidentical hormone replacement therapy is not appropriate right now — because of other conditions, medication interactions, or a health picture that requires stabilization first. A specialist can make that call. A monthly subscription service cannot.

Telehealth Changes the Access Equation

The practical problem has always been that hormone specialists are concentrated in academic medical centers and major urban areas. A woman in rural New Hampshire, or in a suburb where the primary option is a large OB-GYN practice, historically had limited access to this level of care without significant travel.

Telehealth eliminates that barrier without compromising clinical quality. A physician-directed telehealth practice can deliver the same assessment, the same clinical rigor, and the same individualized care that an in-person specialist visit would provide — from wherever the patient is. IHA operates this way by design. The physician sees your history, reviews your labs, makes a prescribing decision, and remains responsible for your care through the treatment period. The same oversight that would happen in a specialist's office happens remotely.

If you have raised perimenopause symptoms with your OB-GYN and left without a satisfying path forward, that is not a reflection of your symptoms or your credibility. It is a gap in the system. There are physicians who specialize specifically in this — and through telehealth, they are accessible to you regardless of where you live in New Hampshire.

What OB-GYN Training Actually Covers — and What It Does Not

An obstetrics and gynaecology residency is four years of intensive training in a specific domain: the reproductive system, its diseases, its surgical correction, and the management of pregnancy, delivery, and the immediate postpartum period. OB-GYN physicians are among the most thoroughly trained specialists in medicine. They manage complex high-risk pregnancies, perform highly skilled surgeries, and carry enormous clinical responsibility for two patients — mother and child — simultaneously.

None of that training is specifically designed to produce expertise in longitudinal hormone optimization for perimenopausal women. A 2019 survey of OB-GYN residency program directors published in the journal Menopause found that the median time devoted to menopause education in residency was two hours over four years. Not two hours per year. Two hours, total, across the entire training period. A discipline that will affect every female patient the physician ever treats receives less structured training time than a single complex procedure they may perform a handful of times in a career.

This is not a criticism of individual OB-GYNs. Many develop strong menopause expertise through continuing medical education, fellowship, and clinical experience. But the baseline training does not build it, and most OB-GYN practices are structured around the throughput of obstetric and gynaecologic care — not the slow, longitudinal, lab-intensive work of hormone optimization for a 40-something woman who has no acute gynaecologic condition.

The Primary Care Gap

For many women, the first physician they turn to with perimenopausal symptoms is not the OB-GYN but the primary care physician — the internist or family medicine doctor who sees them for everything else. The primary care gap is similar but different in character. Primary care training provides broad exposure to a wide range of conditions, including menopause — but breadth is not depth. A PCP managing 2,000 patients with dozens of active conditions and a 15-minute appointment schedule is not positioned to provide the level of hormonal assessment and longitudinal management that perimenopause optimization requires.

What typically happens in a primary care encounter for perimenopausal symptoms is a brief assessment, a standard blood panel, and one of a small number of conventional responses: reassurance that the numbers look normal, a referral to the OB-GYN, a prescription for a sleep aid or antidepressant, or — occasionally — a standard HRT prescription without individualization of dose or formulation. Each of these is a reasonable response within the constraints of general practice. None of them is hormone optimization.

What a Specialist Actually Provides

A physician who specializes in hormone optimization approaches perimenopause differently in every stage of the clinical encounter. The intake is more thorough: a detailed symptom timeline, a complete health history that specifically explores the hormonal context, and an assessment of goals that goes beyond "stopping the hot flushes." The laboratory assessment is more comprehensive: a full panel that includes estradiol, progesterone, FSH, LH, testosterone (total and free), DHEA-S, and SHBG — not just the two or three markers that appear on a standard well-woman screen.

The prescribing decision is individualized in a way that general practice prescribing typically is not. The dose of estradiol is calibrated to what the labs show and what the patient's symptom picture suggests — not chosen from a standard menu of available products. The progesterone component is selected with consideration for the patient's sleep architecture, anxiety pattern, and individual progesterone metabolism. If testosterone deficiency is identified, it is addressed specifically rather than lumped into a generalised "hormone therapy" prescription.

Monitoring is built into the protocol — not as an optional add-on but as a standard clinical step. Labs at three months, labs at six months, clinical review at each point to assess symptom response and confirm that levels have reached the therapeutic target. Adjustments made based on that data. This is the clinical cycle that produces the outcomes women are looking for, and it requires a physician who has both the time and the expertise to execute it.

Why IHA's Telehealth Model Works for This

The historical barrier to specialist access has been geographic. A hormone optimization specialist in a major academic medical center might have a waiting list of six months and require patients to travel an hour each way for a 30-minute consultation. Telehealth removes that constraint without removing the clinical standard. IHA's physician-directed program delivers the same comprehensive intake, the same individualized lab-based prescribing, and the same structured monitoring — remotely, from wherever the patient is in New Hampshire, without a waiting list of months.

The BHRT program at IHA is designed around the clinical standard described above: comprehensive labs before prescribing, individualized dosing, and structured follow-up. Medication comes from a licensed, regulated pharmacy. The physician who makes your prescribing decision is named, licensed, and responsible for your care throughout the treatment period. If you have been seen by your OB-GYN or PCP for perimenopausal symptoms and left the conversation without a path forward that felt adequate — that is a gap this program is specifically designed to fill.

How to Have the Conversation With Your Current Doctor

For many women, the first step in addressing perimenopausal hormone changes is a conversation with a physician they already trust — a primary care provider or OB-GYN they have seen for years. That conversation is often frustrating, and understanding why it tends to go poorly helps women advocate more effectively rather than walking away feeling dismissed or confused about what they actually need.

The most common failure mode is framing the conversation around symptoms without anchoring it to specific clinical requests. Describing fatigue, brain fog, mood changes, and sleep disruption to a primary care physician will often result in a depression screening, a thyroid TSH, and a recommendation to consider antidepressants or better sleep habits. These are not unreasonable responses given standard primary care training — but they are incomplete responses to a presentation that may be driven by hormonal changes. The way to shift the conversation is to come in with specific test requests. Ask for a comprehensive hormone panel including estradiol, FSH, progesterone, total and free testosterone, DHEA-S, and SHBG, in addition to a complete metabolic panel and thyroid function tests. If your physician orders only FSH, that is a meaningful gap: FSH becomes elevated only after ovarian function has already declined substantially, making it a late marker of perimenopause rather than a sensitive early indicator.

When results come back "normal," the conversation requires a second layer. Ask your physician what reference range they are using and what the population that reference range is derived from. Most laboratory reference ranges for estradiol, for example, represent a wide band across all cycling women of reproductive age — a value of 35 pg/mL is technically within range but is well below the mean for a woman in her early forties in the mid-follicular phase. Ask specifically: "Given my symptoms and these results, is there a clinical explanation other than perimenopause we should consider, and if not, what level of hormone optimization is within your scope to manage?" That question is harder to deflect than a general complaint about feeling off.

When to seek a second opinion is a straightforward clinical question: if you have reported perimenopausal symptoms consistently across two or more visits, your current physician has not ordered a complete hormone panel, and no treatment plan beyond symptom management has been offered, a second opinion from a provider who specializes in hormonal health is warranted. This is not a criticism of your current physician — it reflects the documented gap in menopause education in standard medical training. It is also not a permanent departure from your existing care relationship. A BHRT specialist can manage the hormonal component of your care while your primary care provider continues to manage your overall health. These relationships are not mutually exclusive, and the best outcomes often involve both.

Telehealth specialist care has made this complementary model significantly more practical. A telehealth menopause specialist can review your labs, conduct a clinical intake, prescribe a monitored protocol, and manage follow-up lab review without requiring you to change your primary care relationship or find an in-person specialist in your area. Your PCP can continue to see you annually, manage your other health concerns, and review notes from your hormone specialist. Many women find that this arrangement actually improves the quality of their primary care conversations, because they arrive with current hormone labs and a documented treatment protocol that gives their PCP useful clinical context.

If your current physician is receptive but unfamiliar with current hormone therapy evidence, sharing specific resources — the Menopause Society's 2022 position statement on hormone therapy, the NAMS 2023 guidelines — is more productive than a general argument about whether hormone therapy is safe. Physicians respond to clinical evidence, and the evidence on the safety and efficacy of appropriately monitored bioidentical hormone therapy for perimenopausal women is substantial. The post on bioidentical vs. synthetic hormones covers the molecular and research distinctions in a form that is accessible to patients and clinically grounded enough to share. If you are also navigating conversations about anxiety or cognitive symptoms, the posts on anxiety and SSRIs and brain fog provide the evidence framing that makes those conversations more productive. Reaching out to a specialist directly is often the fastest path to a complete clinical picture.

One practical note on documentation: when you do see a specialist, bringing a copy of your recent labs — even if they were ordered by your PCP and came back "normal" — gives the specialist important context. Knowing that your estradiol was 38 pg/mL on day five of your cycle, that your TSH was 2.8, and that your fasting insulin was 14 tells a different clinical story than a lab report that says all values within normal range. Specialists trained in hormonal health read lab values contextually — comparing them to where you specifically need to be given your age, your symptoms, and your health goals — rather than simply checking whether you fall inside a population-derived reference band. That contextual reading is what most primary care visits, constrained to fifteen-minute slots and a problem list, cannot reliably perform. It is also what a well-structured telehealth consultation, which allocates time for a complete intake and lab review, is specifically designed to provide. The conversation with your current doctor is worth having, and the framework above makes it more productive. But if it produces a referral to a specialist or prompts you to seek one independently, that outcome is precisely what the advocacy was designed to achieve.

Making the Transition to Specialized Hormonal Care

The practical concern that delays many women from seeking specialized hormonal care is the disruption of their existing medical relationships — the sense that going elsewhere for this kind of assessment is somehow disloyal or implies a criticism of their current physician. Neither is accurate. The reality is that OB-GYN and primary care training allocates very limited time to hormonal optimization in midlife women, and most physicians in those specialties are practicing exactly the standard of care they were trained to provide. The gap is not a failure of individual physicians; it is a structural feature of how medical training currently allocates its attention. Seeking specialized care for a condition that requires specialized training is exactly what the system is designed to support.

IHA's telehealth model is designed to complement existing primary care rather than replace it — most patients continue seeing their OB-GYN or GP for routine preventive care and acute care needs while working with IHA specifically for hormonal optimization and metabolic management. Communication between providers is available when patients want that coordination. The goal is a coherent overall picture of your health, not a fragmented parallel system. A consultation with IHA can begin as a second opinion, a supplement to existing care, or the beginning of a primary hormonal management relationship — whatever fits your current clinical picture and your preferences for how your care is structured.